Lowered circannual urinary melatonin concentrations in episodic cluster headache

Area of Science:

• Neuroendocrinology
• Chronobiology
• Sleep Medicine

Background:

• Melatonin, a hormone regulating circadian rhythms, has been implicated in various neurological disorders.
• Episodic cluster headache is a severe primary headache disorder with poorly understood pathophysiology.
• Previous research suggests potential alterations in melatonin secretion in headache disorders.

Purpose of the Study:

• To compare the circannual secretion patterns of melatonin in patients with episodic cluster headache versus healthy controls.
• To investigate potential correlations between melatonin levels, cluster headache periods, and influencing factors such as smoking.

Main Methods:

• Monthly overnight urine samples were collected over 8–14 months from Swedish and Italian patients with cluster headache and matched healthy controls.
• Melatonin concentrations were analyzed using radioimmunoassay (RIA).
• Statistical analysis included multiple analysis of variance with repeated measurements to assess the effects of disease, time, sex, location, age, and smoking.

Main Results:

• Melatonin concentrations in nocturnal urine were consistently lower in cluster headache patients compared to controls.
• No significant circannual or infraannual rhythmicity of melatonin was observed in either patients or controls.
• Disease status (p < 0.05), sex, geographical location, age, and smoking (p < 0.001) significantly affected melatonin concentrations.

Conclusions:

• Individuals with episodic cluster headache demonstrate persistently reduced nocturnal melatonin secretion.
• The observed lower melatonin levels in patients may be partly attributed to a higher prevalence of smokers within the patient group.
• Further research is recommended to elucidate the relationship between tobacco use and melatonin secretion in the context of cluster headaches.